“…There are some studies in the literature evaluating IMT in populations with other neurological diseases, such as ischaemic stroke (Menezes et al, 2016), amyotrophic lateral sclerosis (ALS; Ferreira, Costa, Plentz, Coronel, & Sbruzzi, 2016;Macpherson, Bassile, & Clare, 2016) and multiple sclerosis (MS; Ferreira et al, 2016;Fry, Pfalzer, Chokshi, Wagner, & Jackson, 2007;Klefbeck & Nedjad, 2003), which showed improvement in muscular strength and respiratory function. However, in addition to these, other benefits can be verified in other diseases, such as heart failure (Caruso et al, 2016;Mello et al, 2012) and chronic obstructive pulmonary disease (Basso-Vanelli et al, 2016), in which IMT was able to improve thoracic mobility, increase functional capacity, besides autonomic and peripheral controls, and quality of life.…”